News
News releases on April 7, 2024
Every news release public companies put out on April 7, 2024 (UTC): 17 news releases, newest first. Open any release to read it.
Patriot Announces Final 2023 Drill Hole Results for the CV13 and CV9 Pegmatites, Corvette, Quebec, Canada
PMET Resources Inc. · Apr 7, 2024
JB Foods: Annual Report 2023
JB Foods Ltd. · Apr 7, 2024
Grasim Industries: Birla Pivot, the B2B e-commerce business unit of Grasim Industries surpasses Rs 1,000 crore revenue in its first year ...
Grasim Industries Ltd. · Apr 7, 2024
Press Release Apr 07 2024
Signatureglobal (India) Limited · Apr 7, 2024
Sale of Share held in the Subsidiary - SMB Brokers (Pvt) Ltd
SMB Finance PLC · Apr 7, 2024
Madulsima planations plc announcement as required vy rule 7.13 of the listing rules...
Madulsima Plantations PLC · Apr 7, 2024
Press Release Apr 07 2024
Shoppers Stop Limited · Apr 7, 2024
Press Release Apr 07 2024
Voltas Limited · Apr 7, 2024
Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Mul...
Regeneron Pharmaceuticals, Inc. · Apr 7, 2024
Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome
Ionis Pharmaceuticals, Inc. · Apr 7, 2024
Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin ...
Replimune Group, Inc. · Apr 7, 2024
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Po...
Esperion Therapeutics, Inc. · Apr 7, 2024
Canter Resources Expands the Columbus Project to Approximately 30,000 Acres to Cover West Trending Lithium Brine Target
Canter Resources Corp · Apr 7, 2024
BridgeBio Pharma Presents Cardiac Magnetic Resonance (CMR) Imaging Evidence Consistent with Clinical Improvement Observed in the ATTRibut...
BridgeBio Pharma, Inc. · Apr 7, 2024
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BD...
Black Diamond Therapeutics, Inc. · Apr 7, 2024
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Card...
Arrowhead Pharmaceuticals, Inc. · Apr 7, 2024
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients ...
Alnylam Pharmaceuticals, Inc. · Apr 7, 2024